Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
45.00    2.50 (5.88%)
Bid:
44.00
Ask:
46.00
Spread: 2.00 (4.545%)
Market Cap: £86.34m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Q1 2025 Update

17 Apr 2025 07:00

RNS Number : 3680F
Iofina PLC
17 April 2025
 

17 April 2025

 

Iofina plc

("Iofina", the "Company" or the "Group")

(AIM: IOF)

 

Q1 2025 Corporate Update

IO#11 on Track

 

Iofina plc, specialists in the exploration and production of iodine and manufacturers of specialty chemical products, today provides an update regarding its activities during Q1 2025 (the "Period").

 

In the Period, Iofina Resources produced 124.1 metric tonnes ('MT') of crystalline iodine from its seven IOsorb® plants in western Oklahoma (Q1 2024: 123.7MT).

 

Whilst production during the winter months has always been lower due to the colder temperatures affecting the IOsorb® process, during January and February 2025, Oklahoma experienced extremely low temperatures that affected all our partners' hydrocarbon production operations. Consequently, this led to limited brine water at times being pumped to all our plants. Since early March, the situation has been improving, with the brine water flow to our operations increasing and approaching levels experienced in Q4 2024, but it has not completely recovered to those levels.

 

Given the lower-than-anticipated Q1 2025 production, the Company now expects total iodine production for H1 2025 to be closer to 300MT compared to the previously guided range of 320MT-355MT. The Company will provide a further update on Iofina Resources' production as part of its year-end 2024 financial reporting.

 

Prices and demand for raw iodine have remained strong, with the Company currently selling all crystalline iodine it is producing. The iodine spot price has been consistently above $70/kg in the Period, which is higher than the H2 2024 average price, and the Company expects prices to remain at these levels throughout 2025.

 

The Company has continued to advance its new IOsorb® plant plans with IO#11 on track and progressing well. The initial foundation work for the site has been laid, with the infrastructure now set to be installed. All the major components have been ordered and many are already on site. The Company expects IO#11 to be running in Q3 2025. Positive commercial terms are under discussion on IO#12, whilst performing water chemistry evaluations on targeted areas. The Company is optimistic that IO#12 will be under construction by the end of 2025, with updates announced later in the year.

 

The Company has been closely monitoring the recent tariff impositions that might affect US domestic businesses, but it is pleased to report that there have been no material implications to Iofina so far.

 

 

The Company will publish its 2024 full-year financial results to the market in the coming weeks and hold its AGM in June 2025. 

 

President and CEO, Dr. Tom Becker, commented:

"As a leading North American iodine producer, we were encouraged by the strength of both the iodine market and prices achieved in Q1 2025. Whilst the impact of the extreme winter weather has been frustrating, we continue to work closely with all our partners to adjust their water gathering systems to maximise brine water flow to our plants. All our plants are in good working order, and we remain optimistic for the rest of 2025 in terms of production, capitalising on the strong iodine market and switching on IO#11 as planned in Q3 2025."

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

Enquiries:

 

Iofina plc

Dr. Tom Becker

CEO & President

Tel: +44 (0)20 3006 3135

 

Nomad & Broker:

Canaccord Genuity Limited

Henry Fitzgerald-O'Connor/Harry Rees

Tel: +44 (0)20 7523 8000

 

Financial PR and Media Contact:

Yellow Jersey PR Limited

Charles Goodwin/Shivantha Thambirajah/Zara McKinlay

Tel: +44 (0)7747 788 221/+44 (0)7983 521 488

 

About Iofina:

Iofina plc (AIM: IOF) is a vertically integrated company that specialises in the production of Iodine and the manufacturing of specialty chemical products. Iofina is the second largest producer of iodine in North America and operates the manufacturing entities Iofina Resources and Iofina Chemical.

LEI: 213800QDMFYVRJYYTQ84

ISIN: GB00B2QL5C79

 

Iofina Resources

Iofina Resources develops, builds, owns, and operates iodine extraction plants using Iofina's WET® IOsorb® technology. Iofina operates seven IOsorb® plants in Oklahoma and consistently uses technology and innovation to improve and expand its operations.

 

Iofina Chemical

Iofina Chemical has manufactured high-quality halogen speciality chemicals derived from raw iodine, as well as non-iodine-based products. Iofina Chemical celebrated its 40th anniversary in 2023 as a preeminent halogen-based specialty chemicals company.

 

www.iofina.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFFFIISEIRLIE
Date   Source Headline
5th Jun 20267:00 amRNSAgreement Signed for Additional Brine Water Supply
5th May 20267:00 amRNSNotice of AGM
30th Apr 20264:45 pmRNSHolding(s) in Company
30th Apr 202611:30 amRNSHolding(s) in Company
30th Apr 20267:00 amRNSFinal Results
16th Apr 20261:40 pmRNSHolding(s) in Company
15th Apr 20267:00 amRNSQ1 2026 Corporate Update
20th Mar 202612:25 pmRNSHolding(s) in Company
13th Jan 20267:00 amRNSQ4 2025 Corporate Update
6th Jan 20267:00 amRNSHolding(s) in Company
12th Dec 20257:00 amRNSDirectorate change
5th Dec 20257:00 amRNSAgreement with Western Midstream
12th Nov 20258:15 amRNSHolding(s) in Company
16th Oct 20257:00 amRNSQ3 2025 Update
3rd Oct 20253:32 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSInterim Results
4th Sep 20257:00 amRNSBusiness Update
17th Jul 20257:00 amRNSH1 2025 Update
9th Jul 20257:00 amRNSCapital Reduction
9th Jun 20255:00 pmRNSResult of AGM
14th May 20257:00 amRNSNotice of AGM and Proposed Capital Reduction
12th May 20257:00 amRNS-RInvestor Presentation
12th May 20257:00 amRNSFinal Results
25th Apr 20253:45 pmRNSHolding(s) in Company
17th Apr 20257:00 amRNSQ1 2025 Update
23rd Jan 20257:00 amRNSQ4 2024 Update
18th Dec 20244:45 pmRNSHolding(s) in Company
21st Oct 20247:00 amRNSHolding(s) in Company
18th Oct 20247:00 amRNSQ3 2024 Update
27th Sep 20247:00 amRNSIO#11 Update
20th Sep 20247:00 amRNSInterim Results
13th Sep 20247:00 amRNSIO#10 Iodine Plant Commissioned
16th Jul 20247:00 amRNSH1 Update
27th Jun 202411:04 amRNSHolding(s) in Company
25th Jun 20247:00 amRNSHolding(s) in Company
13th Jun 20241:00 pmRNSResult of AGM
29th May 20244:50 pmRNSLaunch of new website
15th May 20247:00 amRNSNotice of AGM and Resignation of Director
2nd May 20247:00 amRNSFinal Results
16th Apr 20247:00 amRNSQ1 2024 Corporate Update
17th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSQ4 2023 Corporate Update
30th Nov 20237:00 amRNSIO#9 Update
20th Oct 20237:00 amRNSSigned Agreement for IO#10 and Q3 2023 Update
11th Sep 20237:00 amRNSInterim Results
25th Aug 20235:00 pmRNSHolding(s) in Company
24th Jul 20235:00 pmRNSHolding(s) in Company
20th Jul 20237:00 amRNSH1 Update and Updated Loan Facilities
14th Jun 20232:00 pmRNSResult of AGM
14th Jun 20237:00 amRNSIO#9 Iodine Plant Operating

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.